AIDS: Taking a Long-Term View

Hardcover (Print)
Used and New from Other Sellers
Used and New from Other Sellers
from $1.99
Usually ships in 1-2 business days
(Save 94%)
Other sellers (Hardcover)
  • All (17) from $1.99   
  • New (5) from $24.98   
  • Used (12) from $1.99   

Overview

“This book presents a compelling argument by the aids2031 Consortium, showing why the international community must adopt a long-term view of the AIDS pandemic. It reminds us that our actions today are crucial to the survival of millions tomorrow.”

--Kofi A. Annan, Former United Nations Secretary-General

“In the coming years, we need to accelerate our efforts to change the global picture of HIV so that women and children will no longer be vulnerable to HIV infection and will no longer die prematurely of a preventable and manageable disease. This requires leadership, resources for health, social mobilization on prevention, and respect for human rights.”

--Vuyiseka Dubula, General Secretary, Treatment Action Campaign (TAC)

“This important book outlines the challenges and opportunities before us as the AIDS epidemic--and our global response--turns 30. aids2031 gives us a roadmap for the next two decades: By addressing the social and economic forces driving the AIDS epidemic, we can attack both the disease and the root causes of the poverty that is its close companion.”

--Paul Farmer, Chair, Department of Global Health and Social Medicine, Harvard Medical School, and Co-founder, Partners in Health

The definitive report on the AIDS pandemic: where it stands, where it’s headed, what we’ve learned, and the choices we face

Over 25 million people have died from AIDS, and more than 33 million are living with HIV today. While treatments have moved AIDS from a fatal to a chronic disease, it remains the sixth greatest cause of death globally--and many of those infected in the poorest countries don’t have access to treatments. In short, AIDS is a continuing worldwide health crisis.

In this book, the aids2031 Consortium’s experts examine the first 30 years of the AIDS response and propose options for the future, focusing on what needs to be done differently now to change the face of AIDS by 2031, which will mark 50 years since AIDS was first reported.

They address the full scope of the pandemic: basic science, public health, funding, treatment options, and social and societal impacts. Then, they review the full spectrum of possible responses over the next two decades, carefully assess progress, and discuss both persistent and emerging challenges.

Written to be easily understandable by all readers, this book is the single best source of reliable information on where the AIDS pandemic stands today, where it’s headed, and what can be done to create better outcomes between now and 2031.

  • The future of AIDS
    What has been accomplished and what remains to be done
  • Generating new knowledge and using it more effectively
    Focusing scientific research and efficiently applying what it yields
  • Planning for more effective prevention
    Creating programs that work better and offer greater local ownership
  • Financing AIDS programs for the next generation
    Overcoming donor fatigue and other challenges
  • Authoritative, complete, up-to-date, and accessible
  • Covers scientific advances, treatment options, public health, funding, and directions for progress
  • For policymakers, researchers, health professionals, stakeholders, and citizens

The world is approaching a moment of truth. Over the past 30 years, the worldwide mobilization against AIDS has generated historic achievements and prevented millions of deaths. Yet ominous signs suggest that the AIDS response is beginning to fracture.

The global community has repeatedly mobilized to address global health crises only to lose interest prematurely, with catastrophic impact. Will this tragic story be repeated with AIDS? Or will decision-makers chart a healthier, more enlightened course?

In this book, the aids2031 Consortium, a worldwide group of experts, examines the possible future of AIDS, the factors likely to determine its course, and the steps needed to sharply reduce new infections and deaths. It identifies successful strategies that can be strengthened, as well as changes needed to respond more effectively and sustainably.

Read More Show Less

Product Details

  • ISBN-13: 9780132172592
  • Publisher: FT Press
  • Publication date: 12/24/2010
  • Pages: 224
  • Product dimensions: 6.00 (w) x 9.10 (h) x 0.80 (d)

Meet the Author

The aids2031 Consortium includes nine thematic working groups on the topics of modeling, science and technology, social drivers, the programmatic response, financing, communication, leadership, a special look at hyperendemic countries (Southern Africa), and countries in rapid economic transition (focusing on China, India, Indonesia, Malaysia, and Thailand). These nine groups, along with a group of aids2031 young leaders, engaged over 500 people around the world in discussions, debates, and issue-specific analyses on the current and future state of AIDS.

The work of the aids2031 Consortium and its working groups is led by the Steering Committee listed here:

Zackie Achmat, Founder, Treatment Action Campaign, South Africa

Ricardo Baruch, Global Youth Coalition on HIV/AIDS Taskforce, Mexico

Stefano Bertozzi, Director, HIV and Tuberculosis, Global Health Program, Bill & Melinda Gates Foundation, and Chair of the aids2031 Steering Committee

Myung-Hwan Cho, President, AIDS Society of Asia and the Pacific, and Professor, Konkuk University, South Korea

Achmat Dangor, CEO, Nelson Mandela Foundation, South Africa

Paul Delay, Deputy Executive Director, UNAIDS, Switzerland

Alex deWaal, Program Director, HIV/AIDS and Social Transformation, Social Science Research Council, USA

Chris Elias, President, Program for Appropriate Technology in Health (PATH), USA

David de Ferranti, Executive Director, Global Health Initiative, Brookings Institution, USA

William Fisher, Director, Department of International Development, Community and Environment, Clark University, USA

Geoffrey Garnett, Professor, Imperial College London, UK

Denise Gray-Felder, President, Communication for Social Change Consortium, USA

Geeta Rao Gupta, Senior Fellow at the Bill & Melinda Gates Foundation and former President, International Center for Research on Women, USA

Rob Hecht, Principal and Managing Director, Results for Development, USA

Heidi Larson, Executive Director aids2031 and Senior Lecturer at the London School of Hygiene and Tropical Medicine, UK

Callisto Madavo, Professor, Georgetown University, USA

Michael Merson, Director, Duke University Global Health Institute, USA

Sigrun Mogedal, Ambassador on HIV/AIDS, Ministry of Foreign Affairs, Norway

Prasada Rao, Senior Advisor to the Executive Director of UNAIDS and former UNAIDS Regional Director for Asia and the Pacific

Leonardo Simao, Chief Executive, Joachim Chissano Foundation, Mozambique

As Sy, UNICEF Regional Director for East and Southern Africa, and former UNAIDS Director of Partnerships and External Relations

Ex officio members:

Robert Hemmer, National Service of Infectious Diseases, Centre Hospitalier de Luxembourg

Peter Piot, Director of the London School of Hygiene and Tropical Medicine, and former UNAIDS Executive Director

Todd Summers, Senior Advisor for Global Health at ONE, formerly Senior Policy Officer for Global Health, Bill & Melinda Gates Foundation, USA

Writing team:

Stefano Bertozzi, William Fisher, Michael T. Isbell, Lindsay Knight, Heidi Larson, and Peter Piot

Read More Show Less

Table of Contents

Preface ix

Executive summary xi

AIDS timeline xvii

List of acronyms xxiii

Chapter 1: The future of AIDS: a still-unfolding global challenge 1

Chapter 2: Generating knowledge for the future 35

Chapter 3: Using knowledge for a better future 63

Chapter 4: Financing AIDS programs over the next generation 97

Chapter 5: The way forward: recommendations for long-term success 115

aids2031 working papers and additional resources 125

About the authors 131

Acknowledgments 133

Index 135

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)